Parsec Financial Management, Inc. Amgen Inc Transaction History

Parsec Financial Management, Inc.

$2.37 Billion
Q1 2023

A detailed history of Parsec Financial Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 140,418 shares of AMGN stock, worth $45 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

140,418

Previous 142,184 1.24%

Holding current value

$45 Million

Previous $37.3 Million 9.1%

% of portfolio

1.43%

Previous 1.67%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	SELL	$225.79 - $275.2 $398,745 - $486,003	-1,766 Reduced 1.24%	140,418 $33.9 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $786,947 - $999,910	-3,436 Reduced 2.36%	142,184 $37.3 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $1.13 Million - $1.28 Million	-5,051 Reduced 3.35%	145,620 $32.8 Million
Q2 2022 Jul 06, 2022	BUY	$230.71 - $256.74 $518,636 - $577,151	2,248 Added 1.51%	150,671 $36.7 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $1.13 Million - $1.25 Million	5,155 Added 3.6%	148,423 $35.9 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $113,958 - $130,414	-573 Reduced 0.4%	143,268 $32.2 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $1.07 Million - $1.26 Million	-5,049 Reduced 3.39%	143,841 $30.5 Million
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $723,397 - $802,556	-3,097 Reduced 2.04%	148,890 $36.3 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $339,966 - $396,175	1,532 Added 1.02%	151,987 $37.8 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $72,703 - $86,577	336 Added 0.22%	150,455 $34.6 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $123,895 - $137,781	-528 Reduced 0.35%	150,119 $38.2 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $56,178 - $68,938	-284 Reduced 0.19%	150,647 $35.5 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $47,017 - $62,358	-258 Reduced 0.17%	150,931 $30.6 Million
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $201,508 - $259,008	-1,065 Reduced 0.7%	151,189 $36.4 Million
Q3 2019 Oct 23, 2019	SELL	$174.11 - $208.62 $48,924 - $58,622	-281 Reduced 0.18%	152,254 $29.5 Million
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $1.28 Million - $1.5 Million	7,676 Added 5.3%	152,535 $0
Q1 2019 Apr 25, 2019	BUY	$180.87 - $203.88 $851,174 - $959,459	4,706 Added 3.36%	144,859 $27.5 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $547,688 - $639,327	3,070 Added 2.24%	140,153 $27.3 Million
Q3 2018 Oct 30, 2018	BUY	$185.29 - $208.89 $257,553 - $290,357	1,390 Added 1.02%	137,083 $28.4 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $42,674 - $47,933	-257 Reduced 0.19%	135,693 $25 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $342,587 - $400,356	2,022 Added 1.51%	135,950 $23.2 Million
Q4 2017 Jan 26, 2018	BUY	$168.79 - $188.59 $106,337 - $118,811	630 Added 0.47%	133,928 $23.3 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $22.3 Million - $25.5 Million	133,298	133,298 $24.9 Million

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.

Account

Parsec Financial Management, Inc. Amgen Inc Transaction History